Some people are getting shut out when it comes to GLP-1 drugs. Here’s why. - The Washington Post
The Washington PostJuly 25, 2026

A third of state Medicaid programs paid for the drugs for weight loss as of mid-2025. This year it's about one in five, according to a review by The Washington Post.
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our United States coverage. We hold 1541 finance stories in total, and 197 from The Washington Post.
This is a summary of reporting by The Washington Post. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.
